- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05150444
Effects of Intradialytic Cognitive and Physical Exercise Training on Functional Status of Hemodialysis Patients (DIAKOG)
February 12, 2024 updated by: Špela Bogataj, University Medical Centre Ljubljana
Effects of Intradialytic Cognitive and Physical Exercise Training on Functional Status of Hemodialysis Patients: Randomized Interventional Trial
The aim of this study is to investigate the effect of cognitive training combined with physical exercise on cognitive function, physical performance and frailty indicators in the hemodialysis population.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The prevalence of cognitive impairment in hemodialysis (HD) patients is extremely high.
Despite the well-documented benefits of interventions on cognitive function, there is a widespread call for effective strategies that will show the long-term consequences in patients undergoing dialysis.
A randomized controlled intervention trial to examine the effects of a combined non-pharmacological intervention in the form of intradialytic physical exercise and intradialytic cognitive training on cognitive function, indicators of frailty, and physical performance measures in HD patients will be conducted.
The group of patients receiving the study intervention will be compared to the control group receiving standard HD care.
The duration of the intervention will be 12 weeks (3 days a week).
We will use sensitive instruments (cognitive domain tests) to assess cognitive functions.
The primary outcome of the study at 12 weeks will be performance on the Alertness subtest of the computerized Test of Attentional Performance.
Secondary study outcomes will be: Performance in other domains of cognitive function (executive function, psychomotor speed, information processing efficiency, working memory, attention), physical fitness (10 repetition sit-to-stand test, timed up and go test, handgrip strength test, spontaneous gait speed, Stork balance test), and assessment of frailty (Edmonton Frail Scale).
Study outcomes will be assessed at baseline and immediately after the 12-week intervention.
This study will be among the first to test the synergistic effects of a uniquely designed physical exercise and cognitive training intervention on functional status in HD patients.
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Osrednjeslovenska
-
Ljubljana, Osrednjeslovenska, Slovenia, 1000
- University Medical Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- dialysis patients on renal replacement therapy with chronic hemodialysis
- duration of hemodialysis treatment for at least 3 months
- capable of independent walking and independent feeding
Exclusion Criteria:
- the presence of chronic malignant or infectious disease
- uncontrolled arterial hypertension with an average of the last five pre-dialysis blood pressure values above 180/100 mm Hg,
- unstable angina pectoris or Canadian Cardiovascular Society class 2-4,
- heart failure New York Heart Association class 3 and 4,
- the presence of a psychotic illness or a mental disability,
- a condition with an amputated limb (more than 2 fingers on the lower limb and / or more than 2 fingers on the upper limb)
- any other condition that causes the clinical unstability of the patient (i.e. repetitive gastrointestinal hemorrhagies, liver cirrhosis with frequent exacerbations)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive and physical exercise training
This group will perform combined intradialytic cognitive and physical exercise training.
First, they will exercise during dialysis (3 times a week; 12 weeks) for ~30 minutes on a customized ergometer.
They will start with a 3-min warm-up, then the resistance will be implied to each individual according to the rate of perceived exertion of 4th to 5th grade on a 10-grade Borg scale.
After a break, they will be given tablet computers in order to play "brain games" on a CogniFit platform (~30 - 45 min).
|
12 weeks (3 times a week): patients will cycle on an adapted ergometer during their dialysis procedure.
The exercise program will be run by kinesiologists.
Participants will start with 15 minutes of cycling and then gradually increase the time and intensity.
After the physical exercise session, they will continue with cognitive training.
This training will be done on a tablet computer on a CogniFit platform (~30 minutes).
The "brain games" on mentioned platform automatically adapt to individual cognitive abilities.
|
|
No Intervention: Standard care
This group will receive standard hemodialysis care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Test of Attentional Performance (TAP) score
Time Frame: baseline, after 12 weeks
|
The Test of Attentional Performance (TAP) is a software package that can be used primarily to examine attention functions.
The rationale for the selection of the main outcome: low learning effect, most probably affected by physical exercise, attention is one of the most affected cognitive domains in dialysis patients.
From the TAP test battery, subtests Alertness, Selective attention, and Divided attention will be included.
|
baseline, after 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Montreal Cognitive Assessment (MoCA) score
Time Frame: baseline, after 12 weeks
|
Montreal Cognitive Assessment (MoCA) is a global cognitive function assessment tool covering eight cognitive domains and is used to screen patients for cognitive impairment.
|
baseline, after 12 weeks
|
|
Change in Trail Making Test A and B score
Time Frame: baseline, after 12 weeks
|
The psychomotor speed and executive function will be measured by Trail Making Test A and B.
|
baseline, after 12 weeks
|
|
Change in Symbol Digit Modalities Test (SDMT) score
Time Frame: baseline, after 12 weeks
|
Symbol Digit Modalities Test (SDMT) will be used to assess the psychomotor speed, efficiency of information processing, ability to switch between mental sets of the information and to maintain and manipulate information in working memory.
It is a reliable and valid test for assessing information processing speed and efficiency and executive functioning domains.
|
baseline, after 12 weeks
|
|
Change in 10 repetition sit-to-stand test time
Time Frame: baseline, after 12 weeks
|
Performance of the sit-to-stand test involves activation of the lower limb muscles; the test measures lower limb strength.
Participants are required to 10 times stand up from and sit down on an armless chair as quickly as possible.
Their arms should be folded across their chest.
|
baseline, after 12 weeks
|
|
Change in Stork balance test time
Time Frame: baseline, after 12 weeks
|
Stork balance test time as a measure of balance.
|
baseline, after 12 weeks
|
|
Change in frailty score
Time Frame: baseline, after 12 weeks
|
Frailty indicator will be assessed by the Edmonton Frail Scale (EFS).
The EFS score ranges from zero to 17 points.
Severe Frailty is defined as a score of 12-17 possible points; apparent vulnerability is a score of 6-11 points; and non-frail is a score of 5 or less points.
|
baseline, after 12 weeks
|
|
Change in timed-up-and go (TUG) test time
Time Frame: baseline, after 12 weeks
|
The Timed Up and Go (TUG) test is a simple evaluative test used to measure functional mobility.
It will be used to estimate risk of falling and ability to maintain balance while walking and while walking and talking (TUG-dual).
|
baseline, after 12 weeks
|
|
Change in handgrip strength (HGS) test
Time Frame: baseline, after 12 weeks
|
Handgrip strength test as a measure of upper body strength (in kilograms).
|
baseline, after 12 weeks
|
|
Change in spontaneous gait speed
Time Frame: baseline, after 12 weeks
|
Spontaneous gait speed test (4 meters) as a measure of functional mobility (in m/s).
|
baseline, after 12 weeks
|
|
Change in Brain-derived neurotrophic factor (BDNF) concentration
Time Frame: baseline, after 12 weeks
|
BDNF is a neurotrophic protein that promotes neurons' survival and differentiation.
|
baseline, after 12 weeks
|
|
Change in Interleukin-6 concentration
Time Frame: baseline, after 12 weeks
|
Interleukin-6 serum concentration
|
baseline, after 12 weeks
|
|
Change in C-reactive protein (CRP) concentration
Time Frame: baseline, after 12 weeks
|
C-reactive protein serum concentration
|
baseline, after 12 weeks
|
|
Change in hemoglobin concentration
Time Frame: baseline, after 12 weeks
|
Hemoglobin blood concentration
|
baseline, after 12 weeks
|
|
Change in urea concentration
Time Frame: baseline, after 12 weeks
|
Urea serum concentration
|
baseline, after 12 weeks
|
|
Change in phosphate concentration
Time Frame: baseline, after 12 weeks
|
Phosphate serum concentration
|
baseline, after 12 weeks
|
|
Change in albumin concentration
Time Frame: baseline, after 12 weeks
|
Albumin serum concentration
|
baseline, after 12 weeks
|
|
Change in fat tissue index
Time Frame: baseline, after 12 weeks
|
Fat tissue index measured by bioimpedance analysis (BCM Fresenius Medical Care)
|
baseline, after 12 weeks
|
|
Change in lean tissue index
Time Frame: baseline, after 12 weeks
|
Lean tissue index measured by bioimpedance analysis (BCM Fresenius Medical Care)
|
baseline, after 12 weeks
|
|
Change in hematocrit concentration
Time Frame: baseline, after 12 weeks
|
Hematocrit blood concentration
|
baseline, after 12 weeks
|
|
Change in creatinine concentration
Time Frame: baseline, after 12 weeks
|
Creatinine serum concentration
|
baseline, after 12 weeks
|
|
Change in sodium concentration
Time Frame: baseline, after 12 weeks
|
Sodium serum concentration
|
baseline, after 12 weeks
|
|
Change in potassium concentration
Time Frame: baseline, after 12 weeks
|
Potassium serum concentration
|
baseline, after 12 weeks
|
|
Change in Kidney Disease Quality of Life Short Form (KDQoL-SF) score
Time Frame: baseline, after 12 weeks
|
Kidney Disease Quality of Life Short Form (KDQOL-SF) as a measure of quality of life.
The scoring procedure first transforms the raw precoded numeric values of items to a 0-100 possible range, with higher transformed scores always reflecting better quality of life.
Scores are evaluated according to summary scores: a mental component summary (MCS) and a physical component summary (PCS).
|
baseline, after 12 weeks
|
|
Change in mental fatigue
Time Frame: baseline, after 12 weeks
|
Mental fatigue measured by Visual Analogue Scale (M-VAS) ranged 0-100, where higher score indicates higher mental fatigue.
|
baseline, after 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Jadranka Buturović Ponikvar, PhD, University Medical Centre Ljubljana
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 2, 2022
Primary Completion (Actual)
January 25, 2023
Study Completion (Actual)
June 30, 2023
Study Registration Dates
First Submitted
November 25, 2021
First Submitted That Met QC Criteria
November 25, 2021
First Posted (Actual)
December 9, 2021
Study Record Updates
Last Update Posted (Actual)
February 14, 2024
Last Update Submitted That Met QC Criteria
February 12, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Pathologic Processes
- Urologic Diseases
- Neurocognitive Disorders
- Disease Attributes
- Renal Insufficiency
- Cognition Disorders
- Chronic Disease
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Male Urogenital Diseases
- Kidney Diseases
- Renal Insufficiency, Chronic
- Cognitive Dysfunction
Other Study ID Numbers
- Z3-3212
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Kidney Diseases
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
American Academy of Family PhysiciansUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, ChronicUnited States
-
Centre Hospitalier le MansLe Mans UniversiteWithdrawnFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage3 | Chronic Kidney Failure | Chronic Kidney Disease, Stage 4 (Severe)
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
Texas A&M UniversityWithdrawnChronic Kidney FailureUnited States
-
Lund UniversityBaxter Healthcare Corporation; Universidad de CórdobaCompletedEnd Stage Kidney Disease | Chronic Kidney Disease Requiring Chronic DialysisArgentina
-
University of the State of Santa CatarinaUnknownKidney Diseases | Chronic Kidney Diseases | Hemodialysis | Chronic Renal Insufficiency | Renal Dialysis | Chronic Kidney Insufficiency | Chronic Renal DiseasesBrazil
-
Pharmagest InteractiveCompletedChronic Kidney DiseasesFrance
Clinical Trials on Cognitive and physical exercise training
-
The Hong Kong Polytechnic UniversityUniversity of Santo TomasUnknownMild Cognitive ImpairmentPhilippines
-
University of Alabama at BirminghamPulmonary Fibrosis FoundationCompletedIdiopathic Pulmonary FibrosisUnited States
-
Yeditepe UniversityCompletedAlzheimer Disease | Telerehabilitation | Covid-19 Pandemic | Online Physical Exercise | Computerized Cognitive StimulationTurkey
-
Chang Gung Memorial HospitalRecruitingStroke | Mild Cognitive ImpairmentTaiwan
-
Montreal Heart InstituteCompletedCardiovascular DiseasesCanada
-
Ruijin HospitalRenJi Hospital; Huashan Hospital; Shanghai General Hospital, Shanghai Jiao Tong...UnknownCognitive DysfunctionChina
-
Chang Gung Memorial HospitalCompletedMild Cognitive ImpairmentTaiwan
-
University of BarcelonaUniversity of Pittsburgh; Germans Trias i Pujol Hospital; Ministerio de Economía... and other collaboratorsCompletedAging | Cognitive Function 1, SocialSpain
-
University of MichiganCompletedIntervention 1: Cognitive and Physical Training | Intervention 2: Multimodal ExerciseUnited States